Document Migration

WHITE PAPERS AND CASE STUDIES

• Boosting CMC Regulatory Efficiency In Gene Therapy

  Ensure your business stays ahead in today’s complex regulatory environment by implementing robust regulatory affairs strategies that streamline compliance and product approvals.

• Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators

  Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.

• Sole-Provider FSP Model Beats Schedule, Exceeds Expectations

  See how this tight collaboration resulted in the swift acquisition of staffing at levels beyond initial expectations and propelled advancements in processes across a spectrum of workstreams.

• Transforming Environmental Monitoring And Sample Management

  Discover how applying an OpEx framework to environmental monitoring and sample management can optimize workflows, improve resource utilization, and deliver measurable annual cost savings.

• Process Development For Lyophilized Products

  Learn to identify potential product failure points and design robust formulations and processes for lyophilized products backed by solid data.

• OEE And Product Inspection

  Explore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.

• Field Services Productivity: Mobile Solutions To Optimize Operations And Build Your Business

  Equipped with the right mobile devices and integrated applications, field service workers can deliver better quality and speed of service and increase productivity.

• Non-Viral Genetic Modification Using The 4D-Nucleofector LV Unit In CGT

  This paper underscores the 4D-Nucleofector® LV Unit as a pivotal tool for translating genetic modification technologies into scalable, safe, and effective therapeutic solutions.

• ECI Solves MRO's Chromium Contamination Problem With 900 Series Monitor/Controllers

  Cr(VI) is a regulated contaminant in drinking water because it can cause gastrointestinal, liver, and developmental toxicity in humans when ingested. A facility was unable to discharge to their POTW because the CR(VI) concentration in their wastewater stream was over the regulated discharge limit. 

• Why An Integrated Approach Ensures Smooth Entry Into The European Market

  Simplify your EU launch and boost returns. Learn how to manage regulatory hurdles, access a huge patient population, and gain end-to-end commercial support.

• Coordinating Launches To Unlock Your Full North American Potential

  Explore the benefits and misconceptions of a coordinated launch across North America as well as how an integrated approach can increase patient access and optimize revenue potential.

• Streamlining ADC Development: Advantage Of An All-In-One Solution

  Antibody-drug conjugate (ADC) development requires tightly integrated manufacturing. Streamlined, end-to-end solutions reduce complexity, improve quality, and accelerate time-to-market.